19 October 2026

strategyland.uk

Oxford Nanopore Technologies PLC (ONT)

Rank #118 of 280 - Healthcare - UK Equities

Home/Stocks/Healthcare

Oxford Nanopore Technologies PLC

ONT.L·Healthcare·Market Cap £2.1b

Rank #118 of 280

Quantitative Model · 280 Stocks Analysed

£2.13

+66.20% YTD

52W: £0.96 - £2.39

Factor Analysis Summary

Editorial assessment generated from Oxford Nanopore Technologies PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, Oxford Nanopore Technologies PLC (ONT.L) currently holds an overall rank of #118 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include liquidity, where it demonstrates exceptional market liquidity with deep trading volumes that support efficient entry and exit, and market trading, where it demonstrates strong market trading characteristics with favourable volume trends and institutional participation.

Areas requiring attention include profitability (ROE -27.7%, net margin -51.7%), where compressed margins and weak returns on equity weigh on the earnings profile, as well as technical (RSI 66.6), where bearish technical positioning with price trading below key trend indicators.

Within the Healthcare sector, Oxford Nanopore Technologies PLC sits at composite rank #118, trailing the Healthcare peer average (rank 79). Among 7 Healthcare names in our coverage, it ranks above 1 peer and below 5.

The composite profile is weighed down by 3 below-average factor scores, with profitability (rank 262/280) representing the most significant drag on its #118 overall standing.

Strongest Factors

Liquidity — Rank 28/280 (top quartile)
Market Trading — Rank 64/280 (top quartile)
Valuation — Rank 114/280 (middle of the pack)

Weakest Factors

Profitability — Rank 262/280 (below average)
Technical — Rank 205/280 (below average)

Score Analysis

Oxford Nanopore Technologies PLC is ranked #118 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

139/280

Average Score

Liquidity

Excellent28/280

Valuation

Fair114/280

Profitability

Weak262/280

Solvency

Fair128/280

Asset Efficiency

Weak175/280

Mkt Trading

Excellent64/280

Technical

Weak205/280

1. Liquidity

Score: 28/280

How liquid is ONT and can it meet its short-term obligations?

0/6

liquidity criteria met

Metric

Sector Range

Value

Rank

✗

Quick Ratio

1.0 - 2.5

2.87xRank 6/280

Range: 1.0 - 2.5Rank 6/280

✗

Current Ratio

1.5 - 2.5

3.56xRank 41/280

Range: 1.5 - 2.5Rank 41/280

✗

TTM Operating Cash Flow

0.8 - 1.5

-0.59xRank 234/280

Range: 0.8 - 1.5Rank 234/280

–

Liquidity Coverage Ratio

N/A

Range: N/A

✗

Intangible Asset Ratio

5 - 20

0.09xRank 56/280

Range: 5 - 20Rank 56/280

✗

Cash-to-Debt Ratio

0.4 - 1.2

4.36xRank 21/280

Range: 0.4 - 1.2Rank 21/280

Key Liquidity Metrics

Quick Ratio

2.87x

Sector: 1.0 - 2.5

Current Ratio

3.56x

Sector: 1.5 - 2.5

Overall Liquidity Rank

Rank within universe#28/280

Best (1)Worst (280)

2. Valuation

Score: 114/280

Is ONT undervalued compared to its peers and fair value metrics?

2/7

valuation criteria met

Metric

Sector Range

Value

Rank

–

FY27e P/E

15x - 30x

N/A

Range: 15x - 30x

–

FY26e P/E

15x - 30x

N/A

Range: 15x - 30x

–

FY27e Net Div Yld (%)

1.5 - 4.5

N/ARank 207/280

Range: 1.5 - 4.5Rank 207/280

–

Div Payout Ratio

30 - 60

N/ARank 25/280

Range: 30 - 60Rank 25/280

–

Current EV/EBITDA

9.0x - 16.0x

N/A

Range: 9.0x - 16.0x

✓

Current P/TBV

2.0x - 7.0x

3.04xRank 154/280

Range: 2.0x - 7.0xRank 154/280

✓

Current P/B

2.0x - 6.0x

2.68xRank 195/280

Range: 2.0x - 6.0xRank 195/280

Key Valuation Metrics

TTM P/E

Price-to-Earnings

N/A

FY26e P/E

Forward estimate

N/A

FY27e P/E

Forward estimate

N/A

Current P/B

Price-to-Book

2.68x

Current P/TBV

Tangible Book Value

3.04x

Current EV/EBITDA

Enterprise Value

N/A

FY26e EV/EBITDA

Forward estimate

N/A

FY27e EV/EBITDA

Forward estimate

N/A

Dividend

ONT does not currently pay a significant dividend.

—

No dividend data available for this stock.

3. Profitability

Score: 262/280

How profitable is ONT relative to its peers?

0/7

profitability criteria met

Metric

Sector Range

Value

Rank

✗

TTM Profit Margin

6 - 15

-51.7%Rank 271/280

Range: 6 - 15Rank 271/280

✗

T12 FCF Margin

12 - 20

-0.1%Rank 221/280

Range: 12 - 20Rank 221/280

✗

FY27e RoE

12 - 25

-16.6%Rank 201/280

Range: 12 - 25Rank 201/280

✗

FY26 EPS Growth

8 - 15

22.5%Rank 52/280

Range: 8 - 15Rank 52/280

✗

FY27e EPS Growth

8 - 15

44.9%Rank 42/280

Range: 8 - 15Rank 42/280

–

NIM

N/A

Range: N/A

–

Expense Ratio

75 - 87

N/A

Range: 75 - 87

TTM Profit Margin

-51.7%

Current RoCE

-27.7%

FY27e RoE

-16.6%

T12 FCF Margin

-0.1%

EPS Growth

4. Solvency

Score: 128/280

How strong is ONT's balance sheet and financial position?

0/6

solvency criteria met

Metric

Sector Range

Value

Rank

✗

Debt/Eqt

0.2x - 0.7x

0.09xRank 59/280

Range: 0.2x - 0.7xRank 59/280

–

Interest Coverage Ratio

5x - 15x

Rank 260Rank 260/280

Range: 5x - 15xRank 260/280

✗

Net Leverage Ratio

0.5x - 1.5x

4.20xRank 159/280

Range: 0.5x - 1.5xRank 159/280

–

Altman Z-Score (Manufacturing)

<1.10 - >2.60

8.29Rank 88/280

Range: <1.10 - >2.60Rank 88/280

–

Z-Score (Non Manufacturing)

<1.10 - >2.60

Rank 95Rank 95/280

Range: <1.10 - >2.60Rank 95/280

–

CapAdeq Ratio Tier1

N/A

Range: N/A

Key Solvency Metrics

Debt/Eqt

0.09x

Net Leverage Ratio

4.20x

Interest Coverage

Rank 260

T12 FCF Margin

-0.1%

Altman Z-Score

8.29

Safe Zone

01.812.995+

5. Asset Efficiency

Score: 175/280

How efficiently does ONT deploy its assets and intellectual capital?

1/5

asset efficiency criteria met

Metric

Sector Range

Value

Rank

–

Efficiency Ratio

N/A

Range: N/A

✓

TTM Asset Turnover Ratio

0.3x - 0.6x

0.38xRank 150/280

Range: 0.3x - 0.6xRank 150/280

✗

TTM CAPEX/Sales

6 - 10

22.7%Rank 28/280

Range: 6 - 10Rank 28/280

✗

Working Capital Turnover

4x - 7x

0.71xRank 150/280

Range: 4x - 7xRank 150/280

✗

R&D/Sales FY27e

12 - 25

28.8%Rank 6/280

Range: 12 - 25Rank 6/280

Overall Asset Efficiency Rank

Rank within sector peers#175/280

Best (1)Worst (280)

6. Market Trading

Score: 64/280

How liquid and actively traded is ONT?

1/2

market trading criteria met

Metric

Sector Range

Value

Rank

✗

Intraday Sentiment (%)

30 - 60

69.0%Rank 68/280

Range: 30 - 60Rank 68/280

–

10D-Avg v/s 3M-Avg Vol

N/A

238%Rank 50/280

Range: N/ARank 50/280

✓

Avg Directional Index 30D

010 - 40

37.9Rank 10/280

Range: 010 - 40Rank 10/280

–

Parabolic SAR

N/A

237.18Rank 224/280

Range: N/ARank 224/280

–

Stock Rating Rank

N/A

Range: N/A

Market Cap

£2,088,004,206

Enterprise Value

£1,945,004,206

Trading Volume

7. Technical

Score: 205/280

What do the technical indicators say about ONT?

0/5

technical criteria met

Metric

Chart

Sector Range

Value

Rank

–

CMP v/s 52-WH

£2.39£0.96

-10.6%CMP: £2.13

N/A

-10.6%Rank 133/280

£2.39£0.96

-10.6%CMP: £2.13

Range: N/ARank 133/280

–

CMP v/s 52-WL

£2.39£0.96

+123.2%CMP: £2.13

N/A

123.2%Rank 275/280

£2.39£0.96

+123.2%CMP: £2.13

Range: N/ARank 275/280

–

RSI 14D

066.6 - Bullish100

N/A

66.6Rank 50/280

066.6 - Bullish100

Range: N/ARank 50/280

–

MA50 - MA200

£1.36+0.29£1.66

N/A

BullishRank 101/280

£1.36+0.29£1.66

Range: N/ARank 101/280

–

MACD Rank

Golden Cross

MACD: 1.01

N/A

1.01Rank 100/280

Golden Cross

MACD: 1.01

Range: N/ARank 100/280

RSI (14 Day)

66.6

Bullish

0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£1.66

200 SMA£1.36

SignalGolden Cross (Bullish)

MACD1.01

Risk Metrics

Beta

N/A

3-Yr Std Dev

N/A

5-Yr Std Dev

N/A

Peer Comparison

How does ONT compare to other Healthcare stocks?

Overall Rank Comparison

Factor Score Comparison

Stock	Rank	Liquidity	Valuation	Profitability	Solvency	Mkt Trading	Technical
ONT	#118	28	114	262	128	64	205
AZN.L	#4	68	242	82	111	33	248
GNS.L	#63	33	133	153	79	96	277
HIK.L	#73	52	127	186	144	180	107
CVSG.L	#90	60	211	200	191	200	78
CTEC.L	#115	36	182	206	147	236	211
HLN.L	#126	71	222	169	150	240	232

Similar Stocks

Other top-ranked stocks in the Healthcare sector

Hikma Pharmaceuticals PLC

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

Methodology Note

The analysis presented for Oxford Nanopore Technologies PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Strategyland Research Center - strategyland.ukThis report is for informational purposes only. Not financial advice.